Quality of life (QOL) issues in testis cancer have recently assumed great i
mportance for both physicians and patients. Since most of the patients are
going to be long-term survivors, with modern therapeutic approaches, psycho
social difficulties and sexual life problems may become one of the major lo
ng-term complications of testis cancer treatment. QOL studies available dem
onstrate that approximately 10% of the patients will suffer from enduring l
ong-term psychological problems, namely anxiety, depression, fatigue, and d
isrupted intimate relationships. Since these problems develop unrelated to
the therapeutic approach, one has to develop risk profiles predicting psych
ological illness, such as with psychological counseling, prior to the initi
ation of the therapy. Impairment of sexual life and infertility distress re
present other long-term sequelae of testis cancer treatment. The highest in
cidence of sexual dysfunction develops within the first 6 months following
therapy, with most patients recovering within the next 3 years, resulting i
n a 15% rate of long-term sexual dysfunction. This relatively high frequenc
y of sexual problems warrants an adequate counseling before and after thera
py. Future perspectives of QOL research in testis cancer has to concentrate
on the development of a site- specific questionnaire. Since the different
therapeutic strategies in clinical stage 1 testis cancer result in the same
high cure rates but may encounter various levels of psychosocial distress,
QOL appears to represent the most important endpoint end of different trea
tment modalities in the clinical setting of different treatment modalities
and QOL documentation must be integrated in all clinical study protocolls.
QOL studies are important issues in the evaluation of each new future metho
d of treatment modality going to be established for testis cancer.